Funding supports IND-enabling activities for Casma’s CSM-101, a first-in-class TRPML1 agonist targeting lysosomal dysfunction in genetically driven neurodegenerative diseasesCAMBRIDGE, ...
Summary: Workplace attrition threatens operational continuity and clinical trial timelines for life science professionals. The recent shift to remote and decentralized trials presents unique ...
A peer-reviewed, multi-clinic study published in the Journal of Assisted Reproduction and Genetics suggests an epigenetic sperm-quality profile can add missing information for infertile couples and ...
SAN DIEGO, CA / ACCESS Newswire / March 10, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in proven, ...
TIX100 prevented weight regain in mice after semaglutide discontinuationSupports potential role as oral weight maintenance therapy following GLP-1 Receptor Agonist (GLP-1) treatment, addressing a ...
Study to evaluate clinical performance of CyPath® Lung for the early detection of lung cancer in high-risk patientsMurtha Cancer Center Research Program at Uniformed Services University of the Health ...
Opinion
The $30 Billion CBD Question: Should Medicare Reimburse Cannabis Products Without FDA Approval?
"Medicare was built on evidence-based medicine," said Duane Boise, CEO of MMJ International Holdings. "If cannabinoid therapies are going to be reimbursed by federal healthcare programs, they should ...
Innovative glycobiology platform aimed at enhancing the efficacy, safety, and scalability of next-generation antibody therapeutics across multiple disease areasParis, 9 March, 2026 - kyron.bio, a ...
Pilot Programs to Enable Human-led Generative Knowledge DiscoveryCAMBRIDGE, Mass.--(BUSINESS WIRE)--Unreasonable Labs, the company building superintelligence for knowledge discovery, today announced ...
ATLANTA, GA / ACCESS Newswire / March 10, 2026 / The Arthritis Foundation is preparing for its 2026 Cycling Experiences, featuring the Carolina Hills Classic Bike Tour, May 14-17, the California Coast ...
TerSera Therapeutics LLC today announced that it has completed the previously announced sale of its Infusion Specialty Therapies Business Unit (IST), including two specialty medications, Prialt® ...
LUND, SWEDEN / ACCESS Newswire / March 10, 2026 / Alligator Bioscience (STO:ATORX), a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results